Daily Archives: July 10, 2018

Jumio Records Best Sales Quarter in Company History, Fueled by Q2 Growth in Asia Pacific

Jumio’s sales grew by more than 200 percent year over year for three of our last four quarters; the company has recorded quarter over quarter sales growth nine of the last ten quarters

PALO ALTO, Calif., July 10, 2018 (GLOBE NEWSWIRE) — Jumio, the leading AI-powered trusted identity as a service provider, today announced its best sales quarter in company history, ending June 30, 2018, representing a 269 percent increase in sales over the same quarter last year.

SolarWinds Acquires Trusted Metrics, Adding Threat Monitoring and Management to Its IT Management Portfolio

New SolarWinds Threat Monitor Solution Designed for Technology Professionals across the IT Spectrum,
Including IT Operations, DevOps Engineers, and IT Service Providers

AUSTIN, Texas, July 10, 2018 (GLOBE NEWSWIRE) — SolarWinds, a leading provider of powerful and affordable IT management software, today announced that it has acquired Trusted Metrics, a provider of real-time threat monitoring and management software.

ESDS Selects Juniper Networks to Power Future-Ready Cloud in India

ESDS deploys Juniper’s high-performing automated networking solutions to optimize cloud application delivery for maximum speed and scalability

BANGALORE, India, July 10, 2018 (GLOBE NEWSWIRE) — Juniper Networks (NYSE:JNPR), an industry leader in automated, scalable and secure networks, today announced that ESDS, a managed data center service and auto-scalable cloud solution provider, has successfully implemented Juniper’s high-performing networking solutions, including the QFX 5100, EX 4550 and MX 104, which have  enabled rapid and secure cloud application delivery to their customers.

TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History

Ribociclib Combination Therapy in Adjuvant Setting Represents A Promising Therapy Against Breast Cancer

EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) — Translational Research In Oncology (TRIO) today announced a collaboration with Novartis on its upcoming phase III clinical trial of ribociclib with endocrine therapy in the adjuvant treatment of HR-positive, HER2-negative early breast cancer (EBC).

Linking Moscow to new poisoning in UK is absurd, Russia says

Kremlin spokesman Dmitry Peskov on Monday said Russia was sorry to hear that a British woman had died after being poisoned by a nerve agent, but said any suggestion that Russia was involved is absurd.…

VIETNAM’S HA LONG CITY TO HOST ASEAN TOURISM FORUM 2019

HANOI, Vietnam The ASEAN Tourism Forum (ATF) 2019 will take place early next year in the tourism hub of Ha Long City in Vietnam’s Quang Ninh province, reported the Vietnam News, a daily English-language newspaper.…

EC extends yellow card warning on Vietnam’s seafood until January

The European Commission (EC) said it will extend the yellow card warning on Vietnam’s seafood until next January and offered 39 recommendations to help Vietnam fight illegal, unreported, and unregulated (IUU) fishing.…